Royal Philips NV’s $1.1 billion settlement of US lawsuits targeting 5.5 million recalled sleep-apnea devices resolves only current cases and doesn’t set aside funds for potential future cancer claims ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results